Hepatocyte toll-like receptor 4 regulates obesity-induced inflammation and insulin resistance

Nature Communications

Volumn 5, Issue , 2014, Pages

  Jia, Lin ^a   Vianna, Claudia R ^a   Fukuda, Makoto ^a,c   Berglund, Eric D ^a,b   Liu, Chen ^a   Tao, Caroline ^b   Sun, Kai ^b   Liu, Tiemin ^a   Harper, Matthew J ^a   Lee, Charlotte E ^a   Lee, Syann ^a   Scherer, Philipp E ^b   Elmquist, Joel K ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR 4; TLR4 PROTEIN, MOUSE;

DIABETES; DISEASE RESISTANCE; GLUCOSE; HORMONE; OBESITY; RODENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL COUNT; CHRONIC INFLAMMATION; CONTROLLED STUDY; FATTY LIVER; FEMALE; GLUCOSE TOLERANCE; INFANT; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; LIVER CELL; MACROPHAGE; MOUSE; NONHUMAN; OBESITY; PROTEIN FUNCTION; RECEPTOR UPREGULATION; WHITE ADIPOSE TISSUE; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DIABETES MELLITUS, TYPE 2; ENZYME ACTIVATION; ENZYMOLOGY; GENETICS; GLUCOSE TOLERANCE TEST; IMMUNOLOGY; INFLAMMATION; KNOCKOUT MOUSE; LIVER; METABOLISM; PATHOLOGY;

ADIPOSE TISSUE, WHITE; ANIMALS; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; ENZYME ACTIVATION; FATTY LIVER; GLUCOSE TOLERANCE TEST; HEPATOCYTES; INFLAMMATION; INSULIN RESISTANCE; LIVER; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OBESITY; TOLL-LIKE RECEPTOR 4;

EID: 84900457238     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms4878     Document Type: Article

References (45)

1. Xu, H. et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112, 1821-1830 (2003). (Pubitemid 38063705)
2. Weisberg, S. P. et al. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796-1808 (2003). (Pubitemid 38063703)
3. Glass, C. K. & Olefsky, J. M. Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab. 15, 635-645 (2012).
4. Cani, P. D. et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761-1772 (2007). (Pubitemid 47025442)
5. Erridge, C., Attina, T., Spickett, C. M. & Webb, D. J. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am. J. Clin. Nutr. 86, 1286-1292 (2007). (Pubitemid 350126229)
6. O'Neill, L. A., Golenbock, D. & Bowie, A. G. The history of Toll-like receptors-redefining innate immunity. Na. Rev. Immunol. 13, 453-460 (2013).
7. Kim, F. et al. Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circ. Res. 100, 1589-1596 (2007). (Pubitemid 46897262)
8. Poggi, M. et al. C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet. Diabetologia 50, 1267-1276 (2007). (Pubitemid 46701560)
9. Shi, H. et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 116, 3015-3025 (2006). (Pubitemid 44684486)
10. Suganami, T. et al. Attenuation of obesity-induced adipose tissue inflammation in C3H/HeJ mice carrying a Toll-like receptor 4 mutation. Biochem. Biophys. Res. Commun. 354, 45-49 (2007). (Pubitemid 46123196)
11. Tsukumo, D. M. et al. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 56, 1986-1998 (2007). (Pubitemid 47195825)
12. Cai, D. et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat. Med. 11, 183-190 (2005). (Pubitemid 40321354)
13. Arkan, M. C. et al. IKK-beta links inflammation to obesity-induced insulin resistance. Nat. Med. 11, 191-198 (2005). (Pubitemid 40321355)
14. Matsumura, T., Ito, A., Takii, T., Hayashi, H. & Onozaki, K. Endotoxin and cytokine regulation of toll-like receptor (TLR) 2 and TLR4 gene expression in murine liver and hepatocytes. J. Interferon Cytokine Res. 20, 915-921 (2000).
15. Machida, K. et al. Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog. Proc. Natl Acad. Sci. USA 106, 1548-1553 (2009).
16. Seki, E. et al. TLR4 enhances TGF-beta signalling and hepatic fibrosis. Nat. Med. 13, 1324-1332 (2007). (Pubitemid 350073596)
17. Liu, S. et al. Role of toll-like receptors in changes in gene expression and NF-kappa B activation in mouse hepatocytes stimulated with lipopolysaccharide. Infection Immunity 70, 3433-3442 (2002). (Pubitemid 34665980)
18. Migita, K. et al. Lipopolysaccharide signalling induces serum amyloid A (SAA) synthesis in human hepatocytes in vitro. FEBS Lett. 569, 235-239 (2004). (Pubitemid 38844624)
19. Mozer-Lisewska, I. et al. Tissue localization of Toll-like receptors in biopsy specimens of liver from children infected with hepatitis C virus. Scand. J. Immunol. 62, 407-412 (2005). (Pubitemid 41565394)
20. Wang, A. P. et al. Hepatic expression of toll-like receptor 4 in primary biliary cirrhosis. J. Autoimmun. 25, 85-91 (2005).
21. Olefsky, J. M. & Glass, C. K. Macrophages, inflammation, and insulin resistance. Annu. Rev. Physiol. 72, 219-246 (2010).
22. Saberi, M. et al. Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. Cell Metabol. 10, 419-429 (2009).
23. Orr, J. S. et al. Toll-like receptor 4 deficiency promotes the alternative activation of adipose tissue macrophages. Diabetes 61, 2718-2727 (2012).
24. de Vries, W. N. et al. Expression of Cre recombinase in mouse oocytes: a means to study maternal effect genes. Genesis 26, 110-112 (2000). (Pubitemid 30158090)
25. Hoshino, K. et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162, 3749-3752 (1999). (Pubitemid 29314747)
26. Takeuchi, O. et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11, 443-451 (1999). (Pubitemid 29504199)
27. Uchimura, K. et al. The serine protease prostasin regulates hepatic insulin sensitivity by modulating TLR4 signalling. Nat. Commun. 5, 3428 (2014).
28. Clausen, B. E., Burkhardt, C., Reith, W., Renkawitz, R. & Forster, I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8, 265-277 (1999). (Pubitemid 29523965)
29. Reynolds, C. M. et al. Dietary saturated fatty acids prime the NLRP3 inflammasome via TLR4 in dendritic cells-implications for diet-induced insulin resistance. Mol. Nutr. Food Res. 56, 1212-1222 (2012).
30. Shin, H. et al. B cells from periodontal disease patients express surface Toll-like receptor 4. J. Leukoc. Biol. 85, 648-655 (2009).
31. McDonnell, M. et al. Systemic Toll-like receptor ligands modify B-cell responses in human inflammatory bowel disease. Inflamm. Bowel Dis. 17, 298-307 (2011).
32. Harbrecht, B. G. & Billiar, T. R. The role of nitric oxide in Kupffer cell-hepatocyte interactions. Shock 3, 79-87 (1995).
33. Chen, C. J. et al. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat. Med. 13, 851-856 (2007).
34. Samuel, V. T. & Shulman, G. I. Mechanisms for insulin resistance: common threads and missing links. Cell 148, 852-871 (2012).
35. Yki-Jarvinen, H. Fat in the liver and insulin resistance. Ann. Med. 37, 347-356 (2005). (Pubitemid 41379841)
36. Holland, W. L. et al. Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. J. Clin. Invest. 121, 1858-1870 (2011).
37. Galbo, T. et al. Saturated and unsaturated fat induce hepatic insulin resistance independently of TLR-4 signalling and ceramide synthesis in vivo. Proc. Natl Acad. Sci. USA 110, 12780-12785 (2013).
38. Wunderlich, F. T. et al. Interleukin-6 signalling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action. Cell Metab. 12, 237-249 (2010).
39. Misu, H. et al. A liver-derived secretory protein, selenoprotein P, causes insulin resistance. Cell Metab. 12, 483-495 (2010).
40. El Ouaamari, A. et al. Liver-derived systemic factors drive beta cell hyperplasia in insulin-resistant states. Cell Rep. 3, 401-410 (2013).
41. Radin, M. S., Sinha, S., Bhatt, B. A., Dedousis, N. & O'Doherty, R. M. Inhibition or deletion of the lipopolysaccharide receptor Toll-like receptor-4 confers partial protection against lipid-induced insulin resistance in rodent skeletal muscle. Diabetologia 51, 336-346 (2008).
42. Feingold, K. R. et al. Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. J. Lipid Res. 33, 1765-1776 (1992). (Pubitemid 23006653)
43. Odegaard, J. I. et al. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 447, 1116-1120 (2007). (Pubitemid 47014427)
44. Odegaard, J. I. et al. Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance. Cell Metab. 7, 496-507 (2008). (Pubitemid 351729205)
45. Lee, E. C. et al. A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 73, 56-65 (2001).